26521016|t|VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation.
26521016|a|BACKGROUND: Vacuolar protein sorting 35 (VPS35), a key component of retromer, plays an important role in endosome-to-Golgi retrieval of membrane proteins. Dysfunction of VPS35/retromer is a risk factor for neurodegenerative disorders, including AD (Alzheimer's disease) and PD (Parkinson's disease). However, exactly how VPS35-deficiency contributes to AD or PD pathogenesis remains poorly understood. RESULTS: We found that VPS35-deficiency impaired dendritic spine maturation and decreased glutamatergic transmission. AMPA receptors, GluA1 and GluA2, are significantly reduced in purified synaptosomal and PSD fractions from VPS35-deficient brain. The surface levels of AMPA receptors are also decreased in VPS35-deficient neurons. Additionally, VPS35 interacted with AMPA-type receptors, GluA1 and GluA2. Overexpression of GluA2, but not GluA1, could partially restore the spine maturation deficit in VPS35-deficient neurons. CONCLUSIONS: These results provide evidence for VPS35's function in promoting spine maturation, which is likely through increasing AMPA receptor targeting to the postsynaptic membrane. Perturbation of such a VPS35/retromer function may contribute to the impaired glutamatergic transmission and pathogenesis of neurodegenerative disorders, such as AD and PD.
26521016	0	5	VPS35	Gene	55737
26521016	120	147	Vacuolar protein sorting 35	Gene	55737
26521016	149	154	VPS35	Gene	55737
26521016	278	283	VPS35	Gene	55737
26521016	314	341	neurodegenerative disorders	Disease	MESH:D019636
26521016	353	355	AD	Disease	MESH:D000544
26521016	357	376	Alzheimer's disease	Disease	MESH:D000544
26521016	382	384	PD	Disease	MESH:D010300
26521016	386	405	Parkinson's disease	Disease	MESH:D010300
26521016	429	434	VPS35	Gene	55737
26521016	461	463	AD	Disease	MESH:D000544
26521016	467	469	PD	Disease	MESH:D010300
26521016	533	538	VPS35	Gene	55737
26521016	600	613	glutamatergic	Disease	
26521016	644	649	GluA1	Gene	2890
26521016	654	659	GluA2	Gene	2891
26521016	735	740	VPS35	Gene	55737
26521016	817	822	VPS35	Gene	55737
26521016	856	861	VPS35	Gene	55737
26521016	899	904	GluA1	Gene	2890
26521016	909	914	GluA2	Gene	2891
26521016	934	939	GluA2	Gene	2891
26521016	949	954	GluA1	Gene	2890
26521016	1012	1017	VPS35	Gene	55737
26521016	1085	1090	VPS35	Gene	55737
26521016	1245	1250	VPS35	Gene	55737
26521016	1300	1313	glutamatergic	Disease	
26521016	1347	1374	neurodegenerative disorders	Disease	MESH:D019636
26521016	1384	1386	AD	Disease	MESH:D000544
26521016	1391	1393	PD	Disease	MESH:D010300
26521016	Association	2890	55737
26521016	Association	MESH:D019636	55737
26521016	Association	MESH:D010300	55737
26521016	Association	MESH:D000544	55737
26521016	Positive_Correlation	2891	55737

